Atherothrombosis describes the occurrence of both
atherosclerosis and thrombosis in an artery, a
common feature of peripheral arterial disease.1
It is estimated that 1 in 16 U.S. residents who were
at least 40 years of age in 2000 (approximately 8.5
million persons) had peripheral arterial disease.
Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report
Tuyển tập các báo cáo nghiên cứu khoa học ngành y học tạp chí Medical Sciences dành cho các bạn sinh viên ngành y tham khảo đề tài: Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome...
Many common problems in clinical medicine and general practice relate to arterial
and venous thrombosis. Thrombosis in veins (i.e. venous thromboembolism,
[VTE]) is a permanent problem in various cancers and following surgery, especially
orthopaedic. Other risk factors include diabetes, smoking and obesity. It has
recently been estimated that death due to VTE in the European Community
exceeds those due to AIDS, breast cancer, prostate cancer and road traffic
accidents combined (House of Commons Health Committee, 2005)...
Drug Interactions Not Mediated by Changes in Drug Disposition Drugs may act on separate components of a common process to generate effects greater than either has alone. Antithrombotic therapy with combinations of antiplatelet agents (glycoprotein IIb/IIIa inhibitors, aspirin, clopidogrel) and anticoagulants (warfarin, heparins) are often used in the treatment of vascular disease, although such combinations carry an increased risk of bleeding.